Patient monitoring and treatment systems and methods

Patent metadata

Field	Value
Publication number	US-11957504-B2
Application number	US-202117328928-A
Country	US
Kind code	B2
Filing date	May 24, 2021
Priority date	Jun 23, 2017
Publication date	Apr 16, 2024
Grant date	Apr 16, 2024

Abstract

Non-invasive blood pressure (NIBP) systems and methods are disclosed that measure a blood pressure, and in some examples a beat-to-beat blood pressure, of a patient without restricting blood flow. The NIBP systems determine an efficacy of administered cardiopulmonary resuscitation (CPR) to the patient based on the measured blood pressure and are able to optionally output the CPR efficacy or generate user prompts based on the CPR efficacy. Further, the disclosed NIBP systems can generate user instructions to administer further treatment to the patient based on the CPR efficacy.

First claim

What is claimed is:

1. A medical device, comprising:
an emitter configured to emit a signal toward a blood vessel of a patient, the signal comprising electromagnetic waves or mechanical waves;
a detector configured to receive a reflection of the signal from the blood vessel or blood flowing through the blood vessel; and
a processor configured to:
determine a metric by analyzing the reflection;
determine, by analyzing an electrocardiogram (ECG) of the patient and the metric, whether the patient has pulseless electrical activity (PEA);
output an indication of whether the patient has PEA;
determine, by analyzing the reflection, a geometry of the blood vessel;
determine a severity score indicating a severity of a condition of the patient by analyzing the geometry of the blood vessel and a velocity of the blood flowing through the blood vessel; and
output the severity score.

2. The medical device of claim 1 , wherein the signal comprises ultrasound or light.

3. The medical device of claim 1 , wherein the metric comprises a blood pressure of the patient.

4. The medical device of claim 1 , wherein the processor is configured to determine a metric by analyzing the reflection by:
determining a pulse wave velocity of the blood vessel;
determining a blood velocity of the blood flowing through the blood vessel; and
determining a product of the pulse wave velocity, the blood velocity, and a density of the blood, the metric being equal to the product,
wherein the pulse wave velocity or the blood velocity is determined by analyzing the reflection.

5. The medical device of claim 1 , wherein the processor is further configured to:
determine, by analyzing the reflection, the velocity of the blood flowing through the blood vessel; and
identify the condition of the patient by analyzing the geometry of the blood vessel or the velocity of the blood flowing through the blood vessel.

6. The medical device of claim 5 , wherein the condition of the patient comprises an aneurysm, a return of spontaneous circulation (ROSC), or a vascular blockage.

7. The medical device of claim 1 , wherein the blood vessel is located in a neck or in an abdomen of the patient.

8. A method, comprising:
emitting a signal toward a blood vessel of a patient, the signal comprising electromagnetic waves or mechanical waves;
detecting a reflection of the signal from the blood vessel or blood flowing through the blood vessel;
determining a metric by analyzing the reflection;
determining, by analyzing an electrocardiogram (ECG) of the patient and the metric, whether the patient has pulseless electrical activity (PEA); and
outputting an indication of whether the patient has PEA,
wherein determining the metric by analyzing the reflection comprises:
determining a pulse wave velocity of the blood vessel, and
determining an instantaneous blood velocity of the blood flowing through the blood vessel, wherein the pulse wave velocity and the instantaneous blood velocity are determined simultaneously.

9. The method of claim 8 , wherein the signal comprises ultrasound or light.

10. The method of claim 8 , wherein the metric comprises a blood pressure of the patient.

11. The method of claim 8 , wherein determining the metric by analyzing the reflection further comprises:
determining a product of the pulse wave velocity, the instantaneous blood velocity, and a density of the blood, the metric being equal to the product,
wherein the pulse wave velocity or the instantaneous blood velocity is determined based on the reflection.

12. The method of claim 8 , further comprising:
determining, by analyzing the reflection, a geometry of the blood vessel or a velocity of the blood flowing through the blood vessel; and
identifying a condition of the patient by analyzing the geometry of the blood vessel or the velocity of the blood flowing through the blood vessel.

13. The method of claim 11 , further comprising:
determining, by analyzing a geometry of the blood vessel or the velocity of the blood flowing through the blood vessel, a severity score indicating a severity of a condition of the patient; and
outputting the severity score.

14. The method of claim 11 , wherein a condition of the patient comprises an aneurysm, a return of spontaneous circulation (ROSC), or a vascular blockage.

15. The method of claim 8 , wherein the blood vessel is located in a neck or in an abdomen of the patient.

16. The medical device of claim 1 , further comprising:
a sensor configured to detect the ECG of the patient,
wherein:
the signal comprises an ultrasound signal,
determining the metric based on the reflection comprises:
determining a pulse wave velocity by analyzing the reflection of the ultrasound signal from the blood vessel;
determining a velocity of the blood flowing through the blood vessel by analyzing the reflection of the ultrasound signal from the blood flowing through the blood vessel; and
determining a blood pressure of the patient as a function of the pulse wave velocity and the velocity of the blood flowing through the blood vessel, and
determining whether the patient has PEA further comprises analyzing the blood pressure.

17. The medical device of claim 1 , wherein the condition of the patient comprises an aneurysm, a return of spontaneous circulation (ROSC), or a vascular blockage.

18. The medical device of claim 16 , wherein the blood vessel is located in a neck or in an abdomen of the patient.

19. A medical device, comprising:
an emitter configured to emit a signal toward a blood vessel of a patient, the signal comprising electromagnetic waves or mechanical waves;
a detector configured to receive a reflection of the signal from the blood vessel or blood flowing through the blood vessel; and
a processor configured to:
determine a metric by analyzing the reflection;
determine, by analyzing an electrocardiogram (ECG) of the patient and the metric, whether the patient has pulseless electrical activity (PEA); and

output an indication of whether the patient has PEA,
wherein determining the metric by analyzing the reflection comprises:
determining a pulse wave velocity of the blood vessel, and

determining an instantaneous blood velocity of the blood flowing through the blood vessel, wherein the pulse wave velocity and the instantaneous blood velocity are determined simultaneously.

Assignees

• Stryker Corp

Inventors

• Siedenburg Clinton T
• Lounsbery Arthur T
• Smith Mitchell A
• Walker Robert G

Classifications

• A61B5/349

  Detecting specific parameters of the electrocardiograph cycle · CPC title

• A61B8/04 Primary

  Measuring blood pressure · CPC title

• A61B5/0022

  Monitoring a patient using a global network, e.g. telephone networks, internet · CPC title

• A61B5/0059

  using light, e.g. diagnosis by transillumination, diascopy, fluorescence (photoacoustic A61B5/0093; optical measurement of heart rate A61B5/02416; optical measurement of blood flow A61B5/0261; optical measurement of analytes A61B5/1455) · CPC title

• A61B5/0064

  Body surface scanning · CPC title